
样式: 排序: IF: - GO 导出 标记为已读
-
Persistency in Somatic Symptoms: A Sign of Stagnation in Stimulus- Response Process. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-04-11
Vedat Şar,Görkem Ayas -
Dialectical Behaviour Therapy to Treat Emotion Dysregulation in Autistic adults without Intellectual Disability: A Randomised Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-04-09
Doha Bemmouna,Emmett Rabot,Romain Coutelle,François Lefebvre,Sébastien Weibel,Luisa WeinerINTRODUCTION Emotion dysregulation is prevalent in autistic adults without intellectual disability whereby it has been associated with heightened non-suicidal self-injury and suicidal behaviours. Dialectical behaviour therapy (DBT) has shown to be feasible and preliminary findings suggest that it might reduce emotion dysregulation in this population. Yet studies evaluating the efficacy of DBT in this
-
Clinical and Neurophysiological Effects of Robotically-Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Depression. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-04-09
Luke J Hearne,Lachlan Webb,Robin Cash,Conor Robinson,Philip E Mosley,Joanna Ng,Simon T Thwaites,Simon Issa,Jessica Miller,Nga Yan Tse,Andrew Zalesky,Bjorn Burgher,Luca CocchiINTRODUCTION Repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (DLPFC) is an established treatment for refractory major depressive disorder (MDD), but treatment outcomes vary substantially from person to person. Recent evidence suggests that incorporating neuroimaging-based targeting may help improve clinical outcomes. Here, we report the initial clinical
-
Exploring the Black Box: What Happens During Brief Concentrated Exposure and Response Prevention for Obsessive-Compulsive Disorder? Psychother. Psychosom. (IF 16.3) Pub Date : 2025-03-28
Franziska Miegel,Jakob Scheunemann,Saskia Pampuch,Josephine Schultz,Bjarne Hansen,Kristen Hagen,Jürgen Gallinat,Antonia Zapf,Amir H Yassari,Lena JelinekBACKGROUND Brief concentrated exposure and response prevention (cERP) has shown promise as an efficacious treatment for obsessive-compulsive disorder (OCD). with higher response and remission rates compared to the first-line treatment. However, the mechanisms driving this success remain unclear. METHODS This longitudinal study included 56 patients with OCD who underwent cERP (Bergen four-day treatment;
-
Exploring the impact of Metacognitive Interpersonal Therapy on borderline personality disorder: a retrospective observational study using a latent transition analysis of symptoms and functional changes over 12 months. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-03-26
Matteo Aloi,Antonio Semerari,Giulio Amadei,Ilaria Bucci,Livia Colle,Giuseppe Nicolò,Ilaria Riccardi,Cristina Segura-Garcia,Antonino CarcioneINTRODUCTION Borderline personality disorder (BPD) is marked by emotional instability, interpersonal dysfunction, and high comorbidity, posing significant treatment challenges. Metacognitive Interpersonal Therapy (MIT) targets core features of BPD, including metacognitive impairments and emotional dysregulation. This study uses Latent Transition Analysis (LTA) to assess changes in BPD symptoms and
-
Integrating DCPR-R and DSM-5 into clinical psychosomatic practice in Taiwan: Their relationship with psychopathologies and quality of life. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-03-21
Wei-Lieh Huang,Yi-Ting Chiu,Chi-Shin Wu,Bernd Löwe,Shih-Cheng LiaoINTRODUCTION This study aimed to assess the benefit of integrating the Diagnostic Criteria for Psychosomatic Research-Revised (DCPR-R) into the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5). Specifically, it examined whether this integration enhances the understanding of psychopathologies and quality of life (QOL) in psychosomatic medicine. METHODS In this cross-sectional
-
Telephone-guided sleep restriction for insomnia: A randomized sleep diary-controlled trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-03-21
Mathilde I Looman,Tessa F Blanken,Tim M Schoenmakers,Joyce E Reesen,Marieke Effting,Floris E Linnebank,Annemieke van Straten,Jan H Kamphuis,Jaap LanceeINTRODUCTION Insomnia is common, but access to its first-line treatment, Cognitive Behavioral Therapy for Insomnia (CBT-I), is limited. To explore a scalable alternative, we investigated the efficacy of Sleep Restriction Therapy (SRT), a core component of CBT-I, delivered via telephone. METHODS In a randomized controlled trial, 147 adults with insomnia were allocated to 6 weeks of telephone-guided
-
Effects of Meditation and Yoga on Anxiety, Depression and Chronic Inflammation in Patients with Parkinson's Disease: A Randomized Clinical Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-02-28
Jojo Yan Yan Kwok,Lily Man Lee Chan,Charis Ann Lai,Philip Wing Lok Ho,Zoe Yuen-Kiu Choi,Man Auyeung,Shirley Yin Yu Pang,Edmond Pui Hang Choi,Daniel Yee Tak Fong,Doris Sau Fung Yu,Chia-Chin Lin,Richard Walker,Samuel Yeung Shan Wong,Rainbow Tin Hung HoINTRODUCTION Clinical guidelines recommend a holistic approach to Parkinson's disease (PD) care, yet randomized trials examining mindfulness-based interventions in this context are scarce. This study investigated the effects of two mindfulness practices - meditation and yoga - on biopsychosocial outcomes in PD patients, including anxiety symptoms, depressive symptoms, motor/nonmotor symptoms, health-related
-
Eye Movement Desensitization and Reprocessing with and without Dialectical Behavior Therapy for Posttraumatic Stress Disorder and Comorbid Borderline Personality Disorder Symptoms: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-02-27
Aishah Cecile Snoek,Arne van den End,Aartjan T F Beekman,Jack Dekker,Inga Aarts,Matthijs Blankers,Chris Vriend,Odile A van den Heuvel,Nick Lommerse,Kathleen ThomaesINTRODUCTION Comorbidity between posttraumatic stress disorder (PTSD) and borderline personality disorder (BPD) is prevalent. Despite evidence-based therapies, high rates of nonresponse and dropout persist. This study therefore aimed to examine whether the concurrent application of eye movement desensitization and reprocessing (EMDR) for PTSD and dialectical behavior therapy (DBT) for BPD yields better
-
Efficacy of cognitive behavioral therapy and acceptance- and mindfulness-based treatments in adults with bodily distress - a network-meta-analysis. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-02-24
Frederic Maas Genannt Bermpohl,Alexandra MartinINTRODUCTION Many physical complaints cause long-term bodily distress. Meta-analyses show that cognitive behavioral therapy (CBT) and acceptance- and mindfulness-based treatments (AMBT) reduce somatic symptom severity, but evidence on differential efficacy is limited. OBJECTIVE This study evaluates the efficacy of CBT and AMBT for bodily distress (e.g., somatoform disorders, functional somatic syndromes
-
Group Acceptance and Commitment Therapy versus Cognitive Behavioral Therapy/Exposure Response Prevention for Obsessive Compulsive Disorder: A Block Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-02-21
Sara Kerstine Kaya Nielsen,Anne Christine Stuart,Christensen Winding,Mette Øllgaard,Kate Wolitzky-Taylor,Sarah I F Daniel,Signe Vangkilde,Nicole Rosenberg,Ida Hageman,Martin B JørgensenINTRODUCTION Acceptance and Commitment Therapy (ACT) may be as effective for treating Obsessive Compulsive Disorder (OCD) as the gold standard treatment, Cognitive Behavioral Therapy (CBT) with Exposure Response Prevention (ERP), but ACT has never been directly compared to CBT/ERP in a randomized control trial. OBJECTIVE This study aimed to compare the efficacy of group-based ACT and CBT/ERP in two
-
Enhancing the Scalability and Impact of the Motherly App for Postnatal Depression. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-02-06
Qiang Xie,Weiying Chen -
A Tale of Two Treatments: A Randomised Controlled Trial of Mindfulness or Cognitive Behaviour Therapy Delivered Online for People with Rheumatoid Arthritis. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-01-17
Louise Sharpe,Madelyne A Bisby,Rachel E Menzies,Jack Benjamin Boyse,Bethany Richmond,Jemma Todd,Amy-Lee Sesel,Blake F DearINTRODUCTION This study aimed to determine the relative efficacy of mindfulness-based stress reduction (MBSR) or cognitive behaviour therapy (CBT) in comparison to a waitlist control (WLC) for people with rheumatoid arthritis (RA). Participants completed assessments before and after treatment and at 6-month follow-up. METHODS Two hundred and sixty-nine participants with RA were recruited and randomised
-
Supported Mindfulness-Based Self-Help Intervention as an Adjunctive Treatment for Rapid Symptom Change in Emotional Disorders: A Practice-Oriented Multicenter Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-01-14
Yanjuan Li,Yi Zhang,Chun Wang,Jia Luo,Yang Yu,Shixing Feng,Chunxue Wang,Qianwen Xu,Pengchong Wang,Junxuan Chen,Ning Zhang,Qianmei Yu,Yuqing Liu,Danyun Chen,Stefan G Hofmann,Xinghua LiuINTRODUCTION Rapid symptom relief is crucial for individuals with emotional disorders. The current study aimed to determine whether facilitator-supported mindfulness-based self-help (MBSH) intervention as an adjunctive treatment could provide rapid improvement for individuals with emotional disorders. METHODS A practice-oriented randomized controlled trial was conducted on a sample of 302 patients
-
Metacognitive Training for Subjects with Bipolar Disorder: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-01-13
Luisa de Siqueira Rotenberg,Renata Curvello,Clara Nardini,Milene da Silva Franco,Maria Eduarda Carozzino,Taís Boeira Biazus,Thuani Campanha,Alia Garrudo Guirado,Grace O'Malley,Thomas J Stamm,Beny LaferINTRODUCTION Impairments in social cognition in bipolar disorder (BD) have been extensively described in the last decade but few treatment strategies have been studied to address this issue. This study presents findings from a randomized controlled trial (RCT) investigating the efficacy of metacognitive training for bipolar disorder (MCT-BD) compared to Treatment as Usual (TAU) among individuals with
-
Active Components in Internet-Based Cognitive-Behavioral Therapy for Social Anxiety Disorder: A Randomized Full Factorial Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2025-01-10
Dajana Šipka,Rodrigo Lopes,Tobias Krieger,Jan Philipp Klein,Thomas BergerINTRODUCTION Many studies have demonstrated that social anxiety disorder (SAD) can be effectively treated with psychotherapy, particularly cognitive-behavioral therapy (CBT), including internet-based CBT (ICBT). Despite evidence-based treatments, many individuals do not sufficiently benefit from them. Identifying the active components could help improve the effectiveness of SAD treatment. This study
-
Bodily Distress and International Classification of Diseases-11: Advances, Loose Ends, and Some Confusion. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-29
Peter Henningsen,Bernd Löwe -
Hidden Costs: The Clinical and Research Pitfalls of Mistaking Antidepressant Withdrawal for Relapse. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-28
Mark A Horowitz,James Davies -
Neuromodulations in Psychiatric Disorders: Emerging Lines of Definition. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-14
Xiaolei Liu,Hongxing Wang -
Karl Rickels Centenarian: Celebration of a Clinician-Scientist. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-13
Richard Balon -
The Power of a Good Word: Enhancing the Efficacy of Analgesics in Clinical Settings. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-04
Roi Treister,Vered Cohen,Limor Issa,Karine Beiruti Wiegler,Alexander Izakson,Mariana AgostinhoINTRODUCTION Communication between medical staff and patients about treatment efficacy elicits expectations of benefit and improves treatment outcomes. While demonstrated in multiple studies via different research methodologies, uniform communication protocols have not been adopted in clinical practice. Here, we summarize the results of two sister studies aimed at bridging this gap. METHODS Women undergoing
-
Reconsidering Persistent Somatic Symptoms: A Transdiagnostic and Transsymptomatic Approach. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-29
Bernd Löwe,Stephan Zipfel,Omer van den Bergh,Peter Henningsen -
Developing and Testing Complex Interventions in Psychosomatic Medicine. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-25
Christopher Burton -
Efficacy of a Standalone Smartphone Application to Treat Postnatal Depression: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-23
Pedro F Zuccolo,André R Brunoni,Tatiane Borja,Alicia Matijasevich,Guilherme V Polanczyk,Daniel FatoriINTRODUCTION Smartphone app interventions based on cognitive-behavioral therapy (CBT) are promising scalable alternatives for treating mental disorders, but the evidence of their efficacy for postpartum depression is limited. We assessed the efficacy of Motherly, a standalone CBT-based smartphone app, in reducing symptoms of postpartum depression. METHODS Women aged 18-40 with symptoms of postpartum
-
Challenges for the Moral Injury Construct. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-23
Richard A Bryant -
Evolution of Psychotropic Medication Prescription in Young People: Reflection from the Quebec Experience. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-22
Joël Monzée -
Inference-Based Cognitive Behavioral Therapy versus Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder: A Multisite Randomized Controlled Non-Inferiority Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-18
Nadja Wolf,Patricia van Oppen,Adriaan W Hoogendoorn,Odile A van den Heuvel,Harold J G M van Megen,Aniek Broekhuizen,Mirjam Kampman,Daniëlle C Cath,Koen R J Schruers,Saskia M van Es,Tamara Opdam,Anton J L M van Balkom,Henny A D VisserINTRODUCTION Although cognitive behavioral therapy (CBT) effectively treats obsessive-compulsive disorder (OCD), many patients refuse CBT or drop out prematurely, partly because of anxiety regarding exposure and response prevention (ERP) exercises. Inference-based cognitive behavioral therapy (I-CBT) focuses on correcting distorted inferential thinking patterns, enhancing reality-based reasoning, and
-
Study of Rates and Factors Associated to Psychosomatic Syndromes Assessed Using the Diagnostic Criteria for Psychosomatic Research across Different Clinical Settings. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-17
Wei Xu,Wenhao Jiang,Rongjing Ding,Hong Tao,Yanyong Wang,Yanping Tang,Dongfeng Liang,Yuping Wang,Mingwei Wang,Bingwei Chen,Youyong Kong,Lei Liu,Yingying Yue,Liangliang Tan,Lu Yu,Fiammetta Cosci,Yonggui Yuan,INTRODUCTION Diagnostic Criteria for Psychosomatic Research (DCPR) serve as an instrument for identifying and classifying specific psychosomatic syndromes that are not adequately encompassed in standard nosography. The present study aimed at measuring the prevalence of DCPR syndromes in different clinical settings and exploring factors associated to such diagnoses. METHODS A cross-sectional and nationwide
-
The importance of the appropriate use of terms related to body ownership in research using avatars. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-14
Monika Kisielewska,Beata Mirucka -
Reply to Kisielewska and Mirucka: The Crucial Aspect of Ownership Illusions Is Their Strength, Not the Method to Induce Them. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-14
Simone C Behrens,Katrin E Giel,Stephan Zipfel -
Innovative Strategies in Evaluation and Treatment of Burnout in Medical Workers. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-11
Jenny Guidi,Giovanni A Fava -
Enhancing Conceptual Clarity regarding the Construct of Moral Injury. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-07
Sheila Frankfurt O'Brien,Isabelle Baptista,Philip R SzeszkoBACKGROUND The construct of "moral injury" is used widely in the research literature and media to broadly describe the impact of events involving perceived violations of one's sense of right and wrong (herein referred to as "potentially morally injurious events" [PMIEs]). SUMMARY In this theoretical review, we provided a brief overview of the "moral injury" construct and its limitations including the
-
The Role of Online Well-Being Therapy in Overcoming Allostatic Overload in Medical Workers: A Pilot Randomized Controlled Study. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-23
Xiaolei Liu,Penghui Song,Lu Yin,Kun Wang,Boheng Zhu,Xiaomin Huang,Yanyan Niu,Haixia Leng,Qing Xue,Mao Peng,Baoquan Min,Fangfang Shangguan,Peiran Zhang,Wenfeng Zhao,Huang Wang,Jing Lv,Mei Yang,Ping Wang,Dongning Li,Xiaoling Gao,Kun Feng,Keming Yun,Fiammetta Cosci,Hongxing WangINTRODUCTION Stress may lead to allostatic overload. Well-being therapy (WBT) might mitigate it by enhancing psychological well-being and protecting from psychological symptoms. Since no reports are available on the use of WBT in allostatic overload, we evaluated online WBT effects in reducing allostatic overload in medical workers during the coronavirus pandemic. METHODS Sixty-six participants with
-
Should Loneliness Be a Treatment Target? Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-16
Tobias Krieger,Noëmi Seewer -
Childhood Trauma and the Immune System: A Complex Interaction That Can Lead to Biopsychosocial Pathogenesis. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-12
Laiana A Quagliato,Antonio E Nardi -
Rise in Persistent Somatic Syndromes: A Relationship with Systemic Changes in Healthcare? Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-11
Tahir Jokinen -
Response to Philips et al.: Several Fundamental Misconceptions about Evidence-Based Practice. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-05
Sophie Juul,Janus Christian Jakobsen,Emilie Hestbaek,Caroline Barkholt Kamp,Markus Harboe Olsen,Marie Rishede,Frederik Weischer Frandsen,Sune Bo,Stig Poulsen,Per Sørensen,Anthony Bateman,Sebastian Simonsen -
Nocebo and Placebo Effects and Their Implications in Psychotherapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-08-30
Winfried Rief,Marcel Wilhelm -
Reducing Distress from Auditory Verbal Hallucinations: A Multicenter, Parallel, Single-Blind, Randomized Controlled Feasibility Trial of Relating Therapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-08-21
Tania Marie Lincoln,Björn Schlier,Rebecca Müller,Mark Hayward,Anne-Katharina Fladung,Niklas Bergmann,Kerem Böge,Jürgen Gallinat,Candelaria Mahlke,Uwe Gonther,Thomas Lang,Cornelia Exner,Anika Buchholz,Katharina Stahlmann,Antonia Zapf,Geraldine Rauch,Matthias PillnyINTRODUCTION There is a significant demand for interventions that reduce distress related to auditory verbal hallucinations (AVHs). AVH distress is associated with the way voice hearers relate with AVHs. We aimed to establish the feasibility of a randomized controlled trial to demonstrate that adding "Relating Therapy" (RT) to treatment as usual (TAU) is superior to TAU in reducing AVH distress. METHODS
-
Flaws in the Design of a Randomized Controlled Trial Comparing Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-31
Björn Philips,Falk Leichsenring,Henning Jordet,Sigmund Karterud -
Adverse Events of Psychological Interventions: Definitions, Assessment, Current State of the Research and Implications for Research and Clinical Practice. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-29
Jan Philipp Klein,Alexander Rozental,Svenja Sürig,Steffen MoritzBACKGROUND The effectiveness of psychological interventions is undisputed. But while in other fields of health care the safety of interventions is studied alongside effectiveness, adverse events (AEs) have only recently been assessed in clinical studies of psychological interventions. This critical review summarizes the definition, assessment and current research status of AEs of psychological interventions
-
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-23
Fiammetta Cosci,Virginie-Anne Chouinard,Guy ChouinardINTRODUCTION Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may cause withdrawal at dose decrease, discontinuation, or switch. Current diagnostic methods (e.g., DSM) do not take such phenomenon into account. Using a new nosographic classification of withdrawal syndromes due to SSRI/SNRI decrease or discontinuation [by Psychother Psychosom. 2015;84(2):63-71]
-
The Clinical Meaning of Withdrawal with Antidepressant Drugs. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-18
Giovanni A Fava -
The Effectiveness of Dialectical Behavior Therapy Compared to Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-10
Nele Assmann,Anja Schaich,Arnoud Arntz,Till Wagner,Philipp Herzog,Daniel Alvarez-Fischer,Valerija Sipos,Kamila Jauch-Chara,Jan Philipp Klein,Michael Hüppe,Ulrich Schweiger,Eva FassbinderINTRODUCTION In the treatment of borderline personality disorder (BPD), there is empirical support for both dialectical behavior therapy (DBT) and schema therapy (ST); these treatments have never been compared directly. This study examines whether either of them is more effective than the other in treating patients with BPD. METHODS In this randomized, parallel-group, rater-blind clinical trial, outpatients
-
Emotional Changes during Imagery Rescripting of Aversive Social Memories in Social Anxiety Disorder: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26
Rosa J Seinsche,Susanne Fricke,Marie K Neudert,Raphaela I Zimmer,Rudolf Stark,Andrea HermannINTRODUCTION Imagery rescripting (ImRs) is a psychotherapeutic intervention targeting aversive memories. During the three-phase intervention, patients reexperience their aversive memory (phase 1), observe the scene from their adult perspective, and intervene to help their former selves (phase 2), and reexperience it again with the positive changes (phase 3). Previous studies have rarely investigated
-
Prevalence and Rapid Screen Method of Diagnostic Criteria for Psychosomatic Research Syndromes in Human Papillomavirus-Infected Patients. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26
Xuelian Cui,Lixin Ding,Yongjuan Xu,Xiaosong Yuan,Qiaoli Zhang,Chiara Rafanelli,Sara Gostoli,Zhiwei Liu,Jianxin CaoINTRODUCTION The early and rapid identification of psychosomatic symptoms is crucial to prevent harmful outcomes in patients with human papillomavirus (HPV) infection in busy comprehensive clinics. This study aimed to explore the prevalence and rapid screening method of the Diagnostic Criteria for Psychosomatic Research-revised (DCPR) syndromes in patients with HPV infection. METHODS A total of 504
-
The Future of Enhanced Psychotherapy: Towards Precision Psychotherapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26
Stephan Zipfel,Wolfgang Lutz,Silvia Schneider,Elisabeth Schramm,Jaime Delgadillo,Katrin E Giel -
Randomization Bias, Multi-Morbidity, and the Composite Clinical Score. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-18
Ralph I Horwitz,James B Baker,Arnab Ghatak,Mark R Cullen -
The Role of Neurosciences in Clinical Interviewing. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-14
Stefano Pallanti -
Appreciating the Limits and Opportunities of Meta-Analyses to Understand Complex Psychological Trajectories: Reply to da Silveira et al. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-05
Amelia J Scott,Ashleigh B Correa,Madelyne A Bisby,Blake F Dear -
Treating Posttraumatic Stress Disorder: The Complexities of the Clinical Realm. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-05-20
Ulrich Schnyder -
Enhanced Skills Training in Affective and Interpersonal Regulation versus Treatment as Usual for ICD-11 Complex PTSD: A Pilot Randomised Controlled Trial (The RESTORE Trial). Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-30
Thanos Karatzias,Mark Shevlin,Marylène Cloitre,Walter Busuttil,Katherine Graham,Laura Hendrikx,Philip Hyland,Natasha Biscoe,Dominic MurphyINTRODUCTION Complex PTSD (CPTSD) is a relatively new condition in ICD-11. This pilot randomised controlled trial aimed to compare a four-module intervention developed to target all symptoms of ICD-11 CPTSD, namely Enhanced Skills in Affective and Interpersonal Regulation (ESTAIR) with treatment as usual (TAU). The purpose of the study was to assess feasibility, safety, acceptability, and preliminary
-
Efficacy of an Internet- and Mobile-Based Intervention for Subclinical Anxiety and Depression (ICare Prevent) with Two Guidance Formats: Results from a Three-Armed Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-30
Anna-Carlotta Zarski,Kiona K Weisel,Thomas Berger,Tobias Krieger,Michael P Schaub,Matthias Berking,Dennis Görlich,Corinna Jacobi,David D EbertINTRODUCTION Limited research exists on intervention efficacy for comorbid subclinical anxiety and depressive disorders, despite their common co-occurrence. Internet- and mobile-based interventions (IMIs) are promising to reach individuals facing subclinical symptoms. OBJECTIVE This study aimed to evaluate the efficacy of a transdiagnostic and self-tailored IMI in reducing subclinical anxiety and depressive
-
Clinical Use of Staging in Psychiatry. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-18
Giovanni A Fava -
Long-Term Effectiveness of Cognitive Behavioral Therapy in Routine Outpatient Care for Youth with Anxiety Disorders. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-12
Karen Krause,Xiao Chi Zhang,Silvia SchneiderINTRODUCTION This study examined the long-term effectiveness of cognitive behavioral therapy (CBT) (≥ 2 years after the end of therapy) in the routine care of youth (mean 11.95 years; SD = 3.04 years) with primary anxiety disorder (AD). METHODS Two hundred and ten children with any AD as a primary diagnosis and with any comorbidity were included in the "Kids Beating Anxiety (KibA)" clinical trial and
-
The Endeavor to Predict Depression and Anxiety Trajectories in the Context of Chronic Diseases Remains a Formidable Challenge. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-12
Pedro Lucas Santana da Silveira,Guilherme Nobre Nogueira,Marisa Bezerra de Araújo,Fabio Gomes de Matos E Souza,Luísa Weber Bisol -
Indicated Stress Prevention Addressing Adolescents with High Stress Levels Based on Principles of Acceptance and Commitment Therapy: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-08
Franziska Binder,Julian Koenig,Franz Resch,Michael KaessINTRODUCTION Stress affects many adolescents and is associated with physical and mental health symptoms that can have a negative impact on normative development. However, there are very few evidence-based, specific treatment approaches. The aim of the study was to investigate an eight-session group intervention using components of Acceptance and Commitment Therapy (ACT) enriched with elements of CBT
-
The Impact of Online Health Information Seeking on Patients, Clinicians, and Patient-Clinician Relationship. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-26
Vladan Starcevic -
Restoring and Preserving the Clinical Interview. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-15
Kurt Kroenke -
Will Interviewing Become a Lost Art? Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-08
Steven L Dubovsky